Roche´s xCELLigence System: First Cell Analyzer System Installed at AgenoLab in Stuttgart

PENZBERG, Germany--On April 3rd, three months before worldwide launch, Roche Applied Science sold the first xCELLigence System at the Analytica 2008 trade in Munich. In July the system has been installed at AgenoLab GmbH & Co. KG in Stuttgart (Germany), a supplier of contract biotechnology and life science laboratory services. AgenoLab is the first company [...]

Promega and Leica Microsystems Sign Agreement to Develop Fluorescent Ligands

Enabling Live Cell Imaging at the Sub 100 nm Range MADISON, WISCONSIN (August 13, 2008) Promega Corporation announced that it has signed an agreement with Leica Microsystems to enable fluorescent imaging of proteins in live cells. Under the terms of the agreement, Promega will develop fluorescent ligands for its HaloTag fusion proteins, that will be [...]

Cambridge Isotope Laboratories and CellFree Sciences Announce Distribution Agreement

Cambridge Isotope Laboratories Cambridge Isotope Laboratories (CIL), the world's leader in the manufacturing of stable isotope labeled research chemicals has entered into a distributor agreement with CellFree Sciences Co., Ltd. (CFS) for the distribution of CFS's WEPRO Expression Kits and reagents for cell-free protein production for NMR and Mass Spectrometry applications in North America and [...]

Isogen Biosolutions B.V. Is Now Ocimum Biosolutions B.V.

IJSSELSTEIN, Netherlands & HYDERABAD, India--Isogen Biosolutions B.V. has rebranded itself as Ocimum Biosolutions B.V. The aim of the rebranding exercise is to tap the emerging opportunities and need for globalized solutions in Genomics. This represents a significant milestone in company’s history as the company hones its position as the premier integrated global genomics solutions provider. [...]

Sloan-Kettering Institute to Use GeneBio’s Phenyx Protein ID Platform

Geneva, Switzerland – August 12, 2008 - Geneva Bioinformatics (GeneBio) SA today announced that the Sloan-Kettering Institute, part of the Memorial Sloan-Kettering Cancer Center, has licensed GeneBio’s PhenyxServer protein identification and characterization software to be used in the laboratory of Paul Tempst, PhD. Dr. Paul Tempst’s team is one of the five Clinical Proteomic Technology [...]

CombiMatrix Announces Publication of Clinical Validation Study of the HemeScan Array for Chronic Lymphocytic Leukemia

MUKILTEO, Wash., Aug. 12, 2008 (PRIME NEWSWIRE) -- CombiMatrix Corporation (NasdaqGM:CBMX - News) announced today that a retrospective, clinical validation study of its test for Chronic Lymphocytic Leukemia (CLL) is to be published in the September issue of the Journal of Molecular Diagnostics (J Mol Diagn 2008, 10:442-451). This publication augments an earlier publication in [...]

San Diego Security Technology Companies to Join Forces

QRSciences and Spectrum San Diego to Combine SAN DIEGO, Aug. 12 -- Diversified Opportunities, Inc. (OTC Bulletin Board: DVOP - News) announced that it intends to combine the security technology holdings of two emerging providers of homeland security products, QRSciences Pty Ltd ("QRSciences") and Spectrum San Diego, Inc. ("Spectrum"). The combination will result in a [...]

Smiths Detection and Torion Technologies partner to develop highly portable, advanced military & emergency response chemical threat assessment technology

Strategic Partnership to Leverage Proprietary Technology Danbury, CT, 12 August 2008 - Smiths Detection, part of the global technology business Smiths Group, today announced a partnership with Torion Technologies, an emerging leader in miniaturized Gas Chromotography Toroidal Ion Trap Mass Spectrometry (GC-TMS) technology. The alliance enables the joint development of a next-generation, hand-portable GC-TMS system [...]

New Detection Cartridges Extend Applications of

FULLERTON, Calif. (August 12, 2008) – Beckman Coulter, Inc. announces four new cartridges for the PARADIGM Detection Platform, the company’s unique user-configurable and upgradeable multimode reader. The new cartridges increase the total number of interchangeable detection choices to 14, extending platform utility and return on investment for PARADIGM customers. The new options include two additional [...]

BioForce Nanosciences Enters Into Licensing Agreement With Aspera Corp.

Operating Costs to Be Reduced by 20% Annually; BioForce Receives Equity Interest in Aspera; Potential for Licensing Income to BioForce AMES, IA--Aug 12, 2008 -- BioForce Nanosciences Holdings, Inc. (OTC BB:BFNH.OB - News), a producer of integrated biological and mechanical systems for life science researchers at the micro and nano scales, today announced the completion [...]

Access IBO on Knowledge Center